Qingdao Vland Biotech Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 12.48% vs 8.26% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 53.61% vs -3.49% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "345.10",
          "val2": "306.80",
          "chgp": "12.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "28.50",
          "val2": "50.80",
          "chgp": "-43.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.40",
          "val2": "4.30",
          "chgp": "25.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "25.50",
          "val2": "16.60",
          "chgp": "53.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "82.60%",
          "val2": "75.20%",
          "chgp": "0.74%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 4.06% vs 9.39% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 5.75% vs -10.40% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,360.60",
          "val2": "1,307.50",
          "chgp": "4.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "205.40",
          "val2": "225.60",
          "chgp": "-8.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "18.80",
          "val2": "22.80",
          "chgp": "-17.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "29.70",
          "val2": "6.60",
          "chgp": "350.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "97.50",
          "val2": "92.20",
          "chgp": "5.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "64.00%",
          "val2": "86.70%",
          "chgp": "-2.27%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

345.10

306.80

12.48%

Operating Profit (PBDIT) excl Other Income

28.50

50.80

-43.90%

Interest

5.40

4.30

25.58%

Exceptional Items

-0.00

0.00

Consolidate Net Profit

25.50

16.60

53.61%

Operating Profit Margin (Excl OI)

82.60%

75.20%

0.74%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 12.48% vs 8.26% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 53.61% vs -3.49% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,360.60

1,307.50

4.06%

Operating Profit (PBDIT) excl Other Income

205.40

225.60

-8.95%

Interest

18.80

22.80

-17.54%

Exceptional Items

29.70

6.60

350.00%

Consolidate Net Profit

97.50

92.20

5.75%

Operating Profit Margin (Excl OI)

64.00%

86.70%

-2.27%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 4.06% vs 9.39% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 5.75% vs -10.40% in Dec 2024

All Annual Results